Literature DB >> 30664260

MiR-744-3p regulates keratinocyte proliferation and differentiation via targeting KLLN in psoriasis.

Changyuan Wang1,2, Jinbao Zong3, Yongxi Li2, Xiaoyan Wang2, Weihua Du3, Linfeng Li1.   

Abstract

Psoriasis is a chronic inflammatory disease, and microRNAs have been reported to regulate the pathogenesis of psoriasis. Up-regulated miR-744-3p level was identified to associate with psoriasis while the precise functions of miR-744-3p in psoriasis were not well-elucidated. We first confirmed the up-regulation of miR-744-3p in psoriasis by measuring its expression level in psoriatic samples. We explored the roles of miR-744-3p on keratinocytes proliferation and differentiation. We searched the targets of miR-744-3p and evaluated the roles of one target, KLLN on keratinocytes proliferation and differentiation. We confirmed the up-regulation of miR-744-3p in psoriatic samples. MiR-744-3p promoted keratinocytes proliferation while inhibited differentiation. MiR-744-3p targeted KLLN and overexpression of miR-744-3p resulted in decreased expression of KLLN. Overexpression of KLLN prevented the effects of miR-744-3p on keratinocytes proliferation and differentiation. MiR-744-3p regulated the proliferation and differentiation of keratinocytes through targeting KLLN in psoriasis.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  KLLN; differentiation; keratinocytes; miRNA; proliferation; psoriasis

Mesh:

Substances:

Year:  2019        PMID: 30664260     DOI: 10.1111/exd.13888

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  11 in total

1.  miR-617 Promotes the Growth of IL-22-Stimulated Keratinocytes Through Regulating FOXO4 Expression.

Authors:  Tao Liu; Xiaomei Feng; Yongmei Liao
Journal:  Biochem Genet       Date:  2020-11-19       Impact factor: 1.890

2.  Skin epigenetics.

Authors:  Bogi Andersen; Sarah Millar
Journal:  Exp Dermatol       Date:  2021-07-05       Impact factor: 4.511

3.  Construction of a lncRNA-miRNA-mRNA network to determine the regulatory roles of lncRNAs in psoriasis.

Authors:  Qianqian Zhou; Qian Yu; Yu Gong; Zhicui Liu; Hui Xu; Yao Wang; Yuling Shi
Journal:  Exp Ther Med       Date:  2019-09-23       Impact factor: 2.447

4.  Datura Metel L. Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis and Inhibits Inflammatory Cytokines Production through TLR7/8-MyD88-NF-κB-NLRP3 Inflammasome Pathway.

Authors:  Bing-You Yang; Yan-Gang Cheng; Yan Liu; Yuan Liu; Jin-Yan Tan; Wei Guan; Shuang Guo; Hai-Xue Kuang
Journal:  Molecules       Date:  2019-06-07       Impact factor: 4.411

Review 5.  MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis.

Authors:  Sandra Domingo; Cristina Solé; Teresa Moliné; Berta Ferrer; Josefina Cortés-Hernández
Journal:  Cells       Date:  2020-12-10       Impact factor: 6.600

6.  The lncRNA H19/miR-766-3p/S1PR3 Axis Contributes to the Hyperproliferation of Keratinocytes and Skin Inflammation in Psoriasis via the AKT/mTOR Pathway.

Authors:  Yuexi He; Xiran Yin; Jianjun Yan; Xue Li; Qing Sun
Journal:  Mediators Inflamm       Date:  2021-12-28       Impact factor: 4.711

7.  Triptolide Inhibits the Proliferation of HaCaT Cells Induced by IL22 via Upregulating miR-181b-5p.

Authors:  Qi He; Bo Zhang; Feng Hu; Jianwen Long; Quan Shi; Xianming Pi; Hongxiang Chen; Jiawen Li
Journal:  Drug Des Devel Ther       Date:  2020-07-22       Impact factor: 4.162

Review 8.  The Role of MicroRNAs in Epidermal Barrier.

Authors:  Ai-Young Lee
Journal:  Int J Mol Sci       Date:  2020-08-12       Impact factor: 5.923

9.  Bronchoalveolar Lavage-microRNAs Are Potential Novel Biomarkers of Outcome After Lung Transplantation.

Authors:  Alessandro Palleschi; Gabriella Gaudioso; Valeria Edefonti; Valeria Musso; Andrea Terrasi; Federico Ambrogi; Sara Franzi; Lorenzo Rosso; Paolo Tarsia; Letizia C Morlacchi; Stefano Ferrero; Mario Nosotti; Valentina Vaira
Journal:  Transplant Direct       Date:  2020-04-09

10.  Cinnamaldehyde inhibits psoriasis‑like inflammation by suppressing proliferation and inflammatory response of keratinocytes via inhibition of NF‑κB and JNK signaling pathways.

Authors:  Zhenzhen Ding; Jingjing Liu; Huangjing Qian; Lingjian Wu; Mingfen Lv
Journal:  Mol Med Rep       Date:  2021-07-19       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.